Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis.
about
Protocol of randomized control trial for effectiveness of angiotensin receptor blockers on blood pressure control among euvolemic hypertensive hemodialysis patients.Comparative Effectiveness of Renin-Angiotensin System Antagonists in Maintenance Dialysis Patients.Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.Angiotensin converting enzyme inhibition increases ADMA concentration in patients on maintenance hemodialysis--a randomized cross-over study.Correlation of Inflammation and Lipoprotein (a) with Hypercoagulability in Hemodialysis Patients.Add-on Protective Effect of Pentoxifylline in Advanced Chronic Kidney Disease Treated with Renin-Angiotensin-Aldosterone System Blockade - A Nationwide Database Analysis.Gene silencing of endothelial von Willebrand Factor attenuates angiotensin II-induced endothelin-1 expression in porcine aortic endothelial cells.Preserving residual renal function in dialysis: what we know.Immunologic Effects of the Renin-Angiotensin System.The crossroad of RAAS modulation, inflammation, and oxidative stress in dialysis patients: light at the end of the tunnel?Primary prevention of myocardial infarction with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients with rheumatoid arthritis-A nationwide cohort study.Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade.New insights into the non-hemostatic role of von Willebrand factor in endothelial protection.Long-term effects of angiotensin II blockade with irbesartan on inflammatory markers in hemodialysis patients: A randomized double blind placebo controlled trial (SAFIR study).C-reactive Protein: Repeated Measurements will Improve Dialysis Patient Care.Heparin use during dialysis sessions induces an increase in the antiangiogenic factor soluble Flt1.Strategies to decrease oxidative stress biomarker levels in human medical conditions: A meta-analysis on 8-iso-prostaglandin F2α.
P2860
Q33621194-04B1801B-5226-430B-8E65-894108AD7C72Q33730477-D690FB45-A053-4913-B264-4BE6A0F7DED9Q34491713-BB6894DD-C2D4-44D7-8479-9373135F9781Q35818228-5DD7B530-1209-4508-904D-9E11C3827C3CQ36176347-387851B6-2C9B-4123-960C-B51BFDFAFD49Q36323673-B4172696-5056-4C03-8CBC-A39F352197DDQ37117491-EA200B8C-BA27-4911-83CE-4EB35141E064Q38251207-10CAA99E-7AF7-4B01-9929-B003CEA0C336Q39115238-E3FE0DAE-5050-4F7C-B061-D8C8A3CC2F4DQ43066725-D5411B99-1BBB-4D37-9F80-C4DA34C22281Q47095887-EAE6B25A-5F12-4FC3-A620-CE28413963FCQ47257220-23B4275A-BC47-43F2-8A27-55DC9F01D482Q48719553-665AA4E3-7C91-41EE-8814-59D1989BBCEBQ51679980-E689F956-7D3B-435E-8415-726B2343A89EQ51723059-4D04895F-2A45-4680-A1A5-80272C089045Q54378242-794AAE0B-36D6-4783-8351-1822BAB0E8F2Q55279804-2BEE8EF7-8EAE-42A0-9F0C-0BF89C70AB0F
P2860
Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Comparative effects of angiote ...... lammation during hemodialysis.
@ast
Comparative effects of angiote ...... lammation during hemodialysis.
@en
type
label
Comparative effects of angiote ...... lammation during hemodialysis.
@ast
Comparative effects of angiote ...... lammation during hemodialysis.
@en
prefLabel
Comparative effects of angiote ...... lammation during hemodialysis.
@ast
Comparative effects of angiote ...... lammation during hemodialysis.
@en
P2093
P2860
P356
P1476
Comparative effects of angiote ...... flammation during hemodialysis
@en
P2093
Deanna R Todd-Tzanetos
Jorge L Gamboa
Mias Pretorius
Nancy J Brown
T Alp Ikizler
P2860
P304
P356
10.1681/ASN.2011030287
P577
2011-12-08T00:00:00Z